Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study
Open Access
- 22 August 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 7 (1), 1-9
- https://doi.org/10.1038/s41598-017-09097-1
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with poorly understood etiology. Increasing evidence suggest that inflammation may play a critical role in the pathogenesis of ALS. Several studies have demonstrated altered levels of blood cytokines in ALS, but results were inconsistent. Therefore, we did a systematic review of studies comparing blood inflammatory cytokines between ALS patients and control subjects, and quantitatively combined the clinical data with a meta-analysis. The systematic review of Pubmed and Web of Science identified 25 studies encompassing 812 ALS patients and 639 control subjects. Random-effects meta-analysis demonstrated that blood tumor necrosis factor-α (TNF; Hedges’ g = 0.655; p = 0.001), TNF receptor 1 (Hedges’ g = 0.741; p < 0.001), interleukin 6 (IL-6; Hedges’ g = 0.25; p = 0.005), IL-1β (Hedges’ g = 0.296; p = 0.038), IL-8 (Hedges’ g = 0.449; p < 0.001) and vascular endothelial growth factor (Hedges’ g = 0.891; p = 0.003) levels were significantly elevated in patients with ALS compared with control subjects. These results substantially enhance our knowledge of the inflammatory response in ALS, and peripheral blood inflammatory cytokines may be used as diagnostic biomarkers for ALS in the future.This publication has 59 references indexed in Scilit:
- Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)Molecular Psychiatry, 2013
- Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patientsJournal of Neuroinflammation, 2011
- VEGF polymorphisms and serum VEGF levels in Parkinson's diseaseNeuroscience Letters, 2011
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patientsJournal of Neuroinflammation, 2010
- Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's diseaseJournal of Neuroimmunology, 2009
- Inflammatory processes in amyotrophic lateral sclerosisMuscle & Nerve, 2002
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001